Farringdon Capital, Ltd. Insulet Corp Transaction History
Farringdon Capital, Ltd.
- $393 Billion
- Q3 2025
A detailed history of Farringdon Capital, Ltd. transactions in Insulet Corp stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 3,176 shares of PODD stock, worth $1.06 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
3,176
Previous 691
359.62%
Holding current value
$1.06 Million
Previous $217 Million
351.65%
% of portfolio
0.25%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding PODD
# of Institutions
909Shares Held
60.3MCall Options Held
325KPut Options Held
557K-
Vanguard Group Inc Valley Forge, PA8.8MShares$2.93 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$2.02 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.55MShares$1.51 Billion0.28% of portfolio
-
State Street Corp Boston, MA3.09MShares$1.03 Billion0.03% of portfolio
-
Baillie Gifford & CO2.09MShares$696 Million0.5% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $23.1B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...